Development of FAP-Targeted Chimeric Antigen Receptor NK-92 Cells for Non-Small Cell Lung Cancer
Cited by 25
Related Papers
Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes
|Frontiers in Immunology|2023|77
Knockdown of METTL14 suppresses the malignant progression of non‑small cell lung cancer by reducing Twist expression
|Oncology Letters|2021|24
Proteomics reveals a therapeutic vulnerability via the combined blockade of APE1 and autophagy in lung cancer A549 cells
|BMC Cancer|2020|20
Combination of 4-1BB and DAP10 promotes proliferation and persistence of NKG2D(bbz) CAR-T cells
|Frontiers in Oncology|2022|12